Woodward (WWD) executive compensation, 2025 proxy

Charles Blankenship, Jr., Chairman and Chief Executive Officer, was paid $10.5M in fiscal 2025, down 6% from $11.2M the year before. The CEO-to-median-employee pay ratio was 149:1, on median employee pay of $70,274.

Filed
December 12, 2025
Annual meeting
January 28, 2026
Pay year
fiscal 2025
Named executives
5
CEO total pay
$10.5M-6% vs prior year
CEO to median employee
149:1median $70,274
CEO pay in equity
56%$5.9M in awards
Prior say-on-pay support
95%of votes cast
Net Sales
$3.6BIncrease of 7% vs. prior year
Diluted EPS
$7.19Increase of 20% vs. prior year
Operating Cash Flow
$471MIncrease of 7% vs. prior year
Returned to Stockholders
$235MShare repurchases and dividends

How Jr. was paid

$10.5M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary11%Stock awards56%Non-equity incentive28%All other compensation5%

Named executive officers

ExecutiveTotal
Charles Blankenship, Jr.Chairman and Chief Executive Officer$10,482,876
William LaceyExecutive Vice President and Chief Financial Officer$2,628,586
Thomas CromwellExecutive Vice President and Chief Operating Officer$3,852,894
Randall HobbsExecutive Vice President and President, Industrial$2,115,894
Terence VoskuilExecutive Vice President and President, Aerospace$2,425,452

What changed and why

  • $11.2MCEO total compensation decreased from $11,177,865 in fiscal 2024 to $10,482,876 in fiscal 2025.
  • $3.6BNet sales reached a record $3.6 billion, representing a 7% increase versus the prior year.
  • 20%Diluted earnings per share increased by 20% to a record $7.19.
  • 95%Over 95% of stock voted approved the say-on-pay proposal in January 2025.
  • $471MNet cash provided by operating activities increased 7% to $471 million.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.